Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211)

William T. Shearer, Mark W. Kline, Stuart L. Abramson, Terence Fenton, Stuart E. Starr, Steven D. Douglas. Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211). Clinical and Diagnostic Laboratory Immunology. 1999. 6: 311-15.

Year

1999

Journal

Clinical and Diagnostic Laboratory Immunology

Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children

Stevens RC, Frenkel LM, Rodman JH. Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children. Pharmacotherapy. 1999. 19: 487.

Year

1999

Journal

Pharmacotherapy

Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter)

Shapiro DE, Sperling RS, Coombs RW. Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter). Lancet. 1999. 354: 156.

Year

1999

Journal

Lancet

The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1

GD McSherry, David E. Shapiro, RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling. The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1. Journal of Pediatrics. 1999. 134: 717-24.

Year

1999

Journal

Journal of Pediatrics

Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies

Mark Mirochnick, Edmund Capparelli, James Connor. Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies. Clinical Pharmacology & Therapeutics. 1999. 66: 16-24.

Year

1999

Journal

Clinical Pharmacology & Therapeutics

Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

I. Celine Hanson, Tracy A. Antonelli, Rhoda S. Sperling, James M. Oleske, Ellen Rae Cooper, Mary Culnane, Mary Glenn Fowler, Leslie A. Kalish, Sophia S. Lee, George McSherry, Lynne Mofenson, David E. Shapiro. Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine.. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999. 20: 463-467.

Year

1999

Journal

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women

Mary Culnane, Bethann Cunningham-Schrader, James M. Oleske, Mary Glenn Fowler, Sophia S. Lee, George D. McSherry, Michael T. Brady, Karen J. O'Donnell, Lynne M. Mofenson, Steven Gortmaker, David E. Shapiro. Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women. The Journal of the American Medical Association. 1999. 281: 151-57.

Year

1999

Journal

The Journal of the American Medical Association

Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Florence H. Yong, Terence Fenton, Richard C. Brundage, Douglas Manion, Nancy M. Ruiz, Merril Gersten, Mark Becker, James McNamara, Lynne M. Mofenson, Lynne M. Mofenson. Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1. New England Journal of Medicine. 1999. 341: 1874-81.

Year

1999

Journal

New England Journal of Medicine

Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.

Ian Marschner, Rebecca Betensky, Victor DeGruttola, Scott M. Hammer, Daniel R. Kuritzkes. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999. 20: 220-7.

Year

1999

Journal

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology